.webp?width=2000&height=630&name=invalid-senior-woman-wheelchair-watching-gym-body-exercise-tablet-living-room%20(1).webp)
Medical cannabis does not treat muscular dystrophy (MD) itself. Current research does not show that it can stop disease progression, repair damaged muscle, or restore lost strength.
What researchers are studying is whether medical cannabis may help manage some of the symptoms muscular dystrophy can cause, including muscle pain, stiffness, disrupted sleep, and reduced appetite. While evidence specific to MD remains limited, there is growing research on cannabinoids for symptoms that also occur in other neurological and chronic pain conditions.
Muscular dystrophy is a group of inherited conditions that gradually weaken and damage skeletal muscles over time. Depending on the type of MD, symptoms may begin in childhood or adulthood and often progress at different rates.
Although treatment plans vary, the primary goals are to preserve mobility, maintain function, and improve quality of life.
Many people living with muscular dystrophy experience symptoms such as:
These symptoms can affect daily activities, independence, and overall well-being, leading some patients to ask whether medical cannabis may be worth discussing with their healthcare team.
Current treatment for muscular dystrophy may include physical therapy, corticosteroids, assistive devices, respiratory support, and medications that address specific symptoms.
Even with comprehensive care, some people continue to experience persistent pain, stiffness, or sleep disturbances.
Rather than asking whether cannabis can reverse muscular dystrophy-which current evidence does not support-researchers are examining whether cannabinoids may help manage certain symptoms that affect quality of life.
Cannabis interacts with the body's endocannabinoid system (ECS), a network involved in regulating pain perception, inflammation, appetite, sleep, and muscle function.
Researchers believe this interaction may explain why cannabinoids are being studied for symptoms such as chronic pain and muscle spasticity.
THC and CBD are being investigated in research involving symptoms such as chronic pain, discomfort, and behavioral responses. Their effects may vary depending on the individual, formulation, and condition being studied.
Although these findings are encouraging, researchers continue to study how they may apply specifically to people living with muscular dystrophy.
Research evaluating medical cannabis specifically for muscular dystrophy remains limited.
Most of what is currently known comes from studies involving chronic pain, multiple sclerosis (MS), or laboratory research rather than large clinical trials in people with MD.
The strongest evidence comes from studies involving multiple sclerosis, another neurological condition where muscle spasticity is common.
A 2026 systematic review and meta-analysis found cannabis-based therapies were associated with improvements in MS-related spasticity during longer treatment periods. However, these findings cannot automatically be applied to muscular dystrophy because no comparable controlled trials have been completed in MD patients.
Chronic pain is one of the most common reasons patients explore medical cannabis.
A 2025 NIH living systematic review found moderate evidence that cannabis-based medicines may reduce certain types of chronic pain in adults. While these studies were not conducted specifically in muscular dystrophy, they provide some insight into symptoms commonly experienced by people living with MD.
Pain and muscle discomfort often contribute to poor sleep.
Some patients using medical cannabis report improved sleep when pain becomes more manageable. However, this evidence is largely observational, and no large clinical trial has specifically evaluated sleep outcomes in muscular dystrophy.
THC has been studied in contexts involving appetite changes and reduced food intake, although this research is not specific to muscular dystrophy. Although this finding is not specific to muscular dystrophy, it may be relevant for individuals who struggle to maintain adequate nutrition.
Despite growing interest, significant gaps remain in the research.
No large randomized clinical trials have evaluated medical cannabis specifically for muscular dystrophy.
A small 2019 survey involving people with myotonic dystrophy found that some participants reported improvements in pain and stiffness after using cannabis. Because surveys rely on patient experiences rather than controlled comparisons, they cannot establish whether cannabis caused those improvements.
Researchers have also studied cannabinoids in animal models of Duchenne muscular dystrophy. While these studies provide valuable scientific information, findings in animals do not reliably predict outcomes in people.
Adding to the uncertainty, a 2023 randomized, double-blind, placebo-controlled trial evaluating cannabis-based medicines for neuropathic pain and spasticity found no significant differences between THC, CBD, combined THC/CBD, and placebo.
Taken together, the evidence suggests that medical cannabis may help some patients manage certain symptoms, but larger human studies are still needed before firm conclusions can be drawn.
Current evidence does not show that medical cannabis can:
Research continues to focus on symptom management rather than disease modification.
Medical cannabis is not appropriate for everyone living with muscular dystrophy.
Potential side effects include:
Because muscular dystrophy already affects muscle strength and mobility, side effects such as dizziness or impaired balance may increase the risk of falls for some patients.
Cannabinoids may also interact with certain prescription medications. Any decision to use medical cannabis should be made with a licensed physician who understands your medical history and current treatment plan.
Whether muscular dystrophy qualifies for medical cannabis depends on state law.
Some states list muscular dystrophy as a qualifying condition, while others approve patients based on qualifying symptoms such as chronic pain or severe muscle spasticity.
A licensed physician can determine whether you meet your state's eligibility requirements.
If you're living with muscular dystrophy and persistent symptoms such as chronic pain, muscle stiffness, or sleep disruption, finding out whether you may qualify for medical cannabis through a licensed physician may be a reasonable next step.
Doctors of Cannabis connects patients to licensed physicians through our telehealth partner network. You only pay if approved.
No. Current evidence does not show that medical cannabis treats, cures, or slows muscular dystrophy. Research has focused on whether it may help manage symptoms such as chronic pain, muscle stiffness, and sleep disruption.
CBD is being studied for its potential anti-inflammatory and calming properties. However, there are currently no large human clinical trials demonstrating that CBD specifically improves symptoms in people with muscular dystrophy.
Cannabis-based medicines have shown benefits for spasticity in some studies involving multiple sclerosis. Whether these findings apply to muscular dystrophy remains uncertain because comparable studies have not yet been completed.
Eligibility varies by state. Some states list muscular dystrophy as a qualifying condition, while others evaluate patients based on symptoms such as chronic pain or severe muscle spasticity. A licensed physician can determine whether you qualify under your state's medical cannabis program.
Medical cannabis is best viewed as a potential symptom-management option rather than a treatment for muscular dystrophy itself. Benefits and risks vary between individuals, and treatment decisions should always be made with physician guidance.
This article is authored by Dr. Erick Kaufman MD. Explore his other expert resources on medical cannabis.
.webp?width=1024&name=invalid-senior-woman-wheelchair-watching-gym-body-exercise-tablet-living-room%20(1).webp)
How Medical Cannabis May Help Patients with Muscular Dystrophy Medical cannabis...
Our team can help you understand the steps to get a medical cannabis card in your state.
